Depomed Inc. President and CEO James Schoeneck has resigned and will be replaced by former Bayer HealthCare LLC and Enzon Pharmaceuticals Inc. CEO Arthur Higgins under a "cooperation agreement" with Starboard Value LP, the company's second largest shareholder.
The agreement – the second settlement between Starboard and Depomed since October – also required the resignation and replacement of...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
